Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedResults information was added to the Study Details page, including the Results First Posted date and posted outcomes. Safety and efficacy data are now available in the study results section.SummaryDifference0.4%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check49 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check63 days agoChange DetectedVersion updated to v3.0.2; the v3.0.1 reference is removed, and the Back to Top element was deleted.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check78 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a comprehensive list of chemical compounds and proteins, while removing several specific terms related to antineoplastic agents and location details.SummaryDifference3%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.